Evaluation of Abuse Potential of Synthetic Opioids and Other Depressants Using In Vivo Pharmacological Studies
Closed Solicitation Posted
- Solicitation number
- 15DDHQ24R00000025
- Agency
-
Drug Enforcement Administration
Department of Justice
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 611310 Colleges, Universities, and Professional Schools
- Place of performance
- Springfield, Virginia 22152, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Drug Enforcement Administration's (DEA) Diversion Control Division (DC) is seeking a contractor to provide investigational study results and methodology for evaluating the abuse potential of synthetic opioids and other depressant drugs. The contractor will be required to conduct appropriate preclinical studies, such as locomotor activity, analgesia, and drug discrimination assays, on test substances in comparison to controls and reference standards. The award will be based on a best value trade-off approach evaluating technical capability, staffing approach, past performance, and cost. Proposals are due on May 17, 2024 at 1:00 PM EST.
This is an unrestricted solicitation with no set-aside designation. The contract will be a firm fixed-price Blanket Purchase Agreement with a 5-year ordering period. The total estimated price per ordering period is $85,000, with 15 test drugs and 2 reference drugs to be evaluated each period. The place of performance is West Springfield, VA 22152, USA.
Notice text
2 versions
Update #2 · Latest ·
**RPF Amendment 0001 to submit Government's response to Questions. **
DEA Diversion Control Division (DC), Drug and Chemical Evaluation Section is responsible for evaluating drugs and chemicals to determine whether these substances have abuse potential of synthetic opioid. The contractor shall provide DEA with investigational study results and a description of the methodology used to conduct the investigation in the form of a study.
Update #1 ·
DEA Diversion Control Division (DC), Drug and Chemical Evaluation Section is responsible for evaluating drugs and chemicals to determine whether these substances have abuse potential of synthetic opioid. The contractor shall provide DEA with investigational study results and a description of the methodology used to conduct the investigation in the form of a study.
Files
| File | Type | Posted |
|---|---|---|
| QA RFP 15DDHQ24R00000025 - Amendment 0001.pdf | ||
| SF-30 Amendment 0001 of Solicitation-signed.pdf | ||
| RFP 15DDHQ24R00000025 Eval of Abuse Potential of Synthetic Opioids-04.19.2024.pdf | ||
| PRICING SHEET TEMPLATE - Attachment 1.xlsx | XLSX spreadsheet | |
| Sample BPA Call Order - Attachment 2.xlsx | XLSX spreadsheet |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | No set-aside | |
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | Total Small Business |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity